SCHEMBL31072211

SCHEMBL31072211

CN(C)c1cccc2c(S(=O)(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OS(=O)(=O)c3cccc4c(N(C)C)cccc34)cccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 3/20 0.37
▸ PRSS1 P07477 3/20 0.37
▸ PRSS2 P07478 3/20 0.37
▸ PRSS3 P35030 3/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ EDNRA P25101 5/20 0.34
▸ FABP3 P05413 1/20 0.34
▸ PTGS2 P35354 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ DUT P33316 1/20 0.33
▸ HDAC4 P56524 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1645476 0.78 CA2 (0.52) F2PRSS1PRSS2PRSS3CA2
SCHEMBL13609012 0.69 CYP1A2 (0.55) F2PRSS1PRSS2PRSS3CA2
SCHEMBL8839047 0.67 CA2 (0.56) F2PRSS1PRSS2PRSS3CA2
SCHEMBL11888406 0.67 CYP1A2 (0.61) F2PRSS1PRSS2PRSS3CA2
SCHEMBL12760595 0.67 CA2 (0.59) F2PRSS1PRSS2PRSS3CA2
SCHEMBL12200891 0.65 CYP1A2 (0.56) F2PRSS1PRSS2PRSS3CA2
SCHEMBL8839039 0.64 CA2 (0.59) F2PRSS1PRSS2PRSS3CA2
SCHEMBL16669352 0.64 CA2 (0.49) F2PRSS1PRSS2PRSS3CA2
SCHEMBL9288054 0.63 CYP1A2 (0.53) F2PRSS1PRSS2PRSS3CA2
SCHEMBL8091038 0.63 CA2 (0.61) F2PRSS1PRSS2PRSS3CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118949146-A Use of a medicated balloon for the treatment of atherosclerosis, stenosis and/or restenosis 凯诺威医疗科技(武汉)有限公司 2024-11-15 — — CN claimed
CN-118949147-A Use of a medicated balloon for the treatment of intracranial atherosclerosis, stenosis and/or restenosis 凯诺威医疗科技(武汉)有限公司 2024-11-15 — — CN claimed
CN-118949145-A Use of a medicated balloon for the treatment of peripheral vascular atherosclerosis, stenosis and/or restenosis 凯诺威医疗科技(武汉)有限公司 2024-11-15 — — CN claimed
CN-118924959-A Medicine-coated balloon coating liquid, medicine-coated balloon and preparation method thereof 凯诺威医疗科技(武汉)有限公司 2024-11-12 — — CN claimed
CN-120022384-A Use of lipid nanoparticles in tumor treatment 中国医学科学院基础医学研究所 2025-05-23 — — CN disclosed
CN-119604304-A Recombinant RNA molecules comprising an untranslated region or a segment encoding spike protein from the Severe acute respiratory coronavirus 2 Omikovia strain 葛兰素史克生物有限公司 2025-03-11 — — CN disclosed
CN-117778533-B Quantitative detection method for nucleic acid in nucleic acid lipid nanoparticle complex 北京剂泰医药科技有限公司 2025-01-07 — — CN disclosed
CN-119236187-A Polymer encapsulated drug particles 吉益医疗公司 2025-01-03 — — CN disclosed
CN-115461096-B Polymer encapsulated drug particles 吉益医疗公司 2024-09-13 — — CN disclosed
CN-114867484-B Pharmaceutical composition containing double-stranded ribonucleic acid for inhibiting expression of complement C5 卫材R&D管理有限公司 2024-08-06 — — CN disclosed
Send feedback